Skip to main content
. 2023 Feb 18;15(4):1031. doi: 10.3390/nu15041031

Table 6.

In vivo therapeutic effects of alkaloids on experimental IBD.

No. Name Type Origin Optimal Doses (/kg Body Weight) or Concentrations Model Potential Mechanism References
104 Capsaicin Vanilloid Capsicum 12 mg DSS-induced acute colitis in Sprague–Dawley rats Inhibits oxidative stress, inflammatory response, and pain signaling. [211]
105 Matrine Quinolizidine alkaloid Sophora flavescens 12 mg/mL TNBS-ethanol-induced ulcerative colitis in Wistar rats Reduces inflammatory response and oxidative stress damage. [212]
20 mg DSS-induced acute colitis in BALB/c mice Improves the integrity of the intestinal barrier, inhibits the PPAR-α signaling pathway, and regulates intestinal flora. [213]
106 Evodiamine Alkaloid Evodia rutaecarpa 30 mg DSS-induced chronic colitis in C57BL/6 mice Reduces the inflammatory response by preventing damage to the intestinal mucosal barrier and regulating the secretion of inflammatory cytokines. [214]
107 Nuciferine Alkaloid Nymphaea caerulea 20 mg DSS-induced acute colitis in BALB/c mice Regulation of gut microbiota homeostasis and immune function in UC mice. [215]
108 Piperine Piperidine alkaloid Piper boehmeriifolium 40 mg TNBS-induced colitis in Sprague–Dawley rats Inhibits IκB-α/NF-κB and induces the tight junction proteins claudin-1, occludin, and ZO-1. [209]
10 mg Acetic acid-induced ulcerative colitis in Swiss albino mice Downregulated the production and expression of inflammatory mediators and reduced the FFA-induced TLR4-mediated inflammatory response. [208]
109 Nicotine Alkaloid Tobacco 10 μg DSS-induced acute colitis in C57BL/6 mice Regulates autophagy via AMPK/mTOR pathway; improves inflammation levels. [40]
110 Neferine Isoquinoline alkaloid Nelumbo nucifera 10 mg DSS-induced acute colitis in C57BL/6J mice Inhibition of inflammatory response. [216]
25 mg DSS-induced acute colitis in C57BL/6 mice Inhibited iNOS, COX-2, receptor-interacting protein 1 (RIP1), RIP3, and increased caspase-8 protein expression in colonic tissues. [217]
111 Anatabine Bipyridines Nicotiana cavicola 20 mg DSS-induced colitis in C57BL/6 mice Improves intestinal inflammation and reduces the production of pro-inflammatory factors. [218]
112 Phellodendrine Alkaloid Phellodendron chinense 30 mg DSS-induced acute colitis in C57BL/6 mice Reduces inflammatory response and promotes autophagy by regulating AMPK-mTOR signaling pathway. [219]
113 Epiisopiloturine Imidazole alkaloid jaborandi 1 mg TNBS-induced colitis in Wistar rats Downregulation of inflammatory processes by inhibiting the synthesis and release of inflammatory products, lipid peroxidation, and expression of inflammatory enzymes. [220]
114 Camptothecin Quinoline alkaloid Camptotheca acuminata 1.5 mg DSS-induced acute colitis in C57BL/6 mice Inhibition of inflammatory responses through AKT, NF-κB and MAPK signaling pathways. [210]
115 Strictosamide Beta-carboline Amsonia orientalis 40 mg DSS-induced acute colitis in BALB/c mice Improving the inflammatory response and NF-κB signaling pathway. [221]
116 Berberine Isoquinoline alkaloid Berberis vulgaris 40 mg DSS-induced acute colitis in BALB/c mice Regulates the intestinal microbiota and protects the mucosal barrier. [206]
100 mg DSS-induced acute colitis in C57BL/6 mice and Sprague–Dawley rats Regulation of intestinal glial cell-intestinal epithelial cell-immune cell interactions. [207]
117 Oxymatrine Quinolizidine alkaloid Sophora pachycarpa 20 mg DSS-induced acute colitis in Kunming mice Reduces inflammatory response and re-establishes antioxidant/oxidant balance. [222]
50 mg DSS-induced acute colitis in BALB/c mice Inhibition of PI3K/AKT signaling pathway. [223]
118 Sophocarpine Quinolizidine alkaloid Daphniphyllum oldhamii 30 mg DSS-induced acute colitis in BALB/c mice Maintains the integrity of the colonic barrier and inhibits the development of colitis. [224]
119 Capnoidine Tetrahydroisoquinoline alkaloid Fumaria capreolata / TNBS-induced acute colitis in C57BL/6 mice Reduction of colonic histological inflammation. [225]
120 Oxyberberine Benzyl tetrahydroisoquinoline alkaloid Thalictrum lucidum 50 mg DSS-induced acute colitis in BALB/c mice Influence on the intestinal epithelial barrier, intestinal microbiota, and TLR4-MyD88-NF-κB pathway. [226]
121 Aloperine Quinolizidine alkaloid Thinicola incana 40 mg DSS-induced acute colitis in BALB/c mice Inhibits the PP2A-Mediated PI3K/Akt/mTOR signaling pathway. [227]
122 Berberrubine Benzyl tetrahydroisoquinoline alkaloid Coptischinensis 20 mg DSS-induced acute colitis in BALB/c mice Reduction of mucosal lesions and inflammation. [228]
123 Sinomenine Morphinane alkaloid Sinomenium acutum 100 mg DSS-induced acute colitis in C57BL/6 mice Alleviation of colitis through the Nrf2/NQO 1 signaling pathway. [229]
124 N-Methylcytisine Quinolizidine alkaloid Thermopsis lanceolata 16 mg DSS-induced acute colitis in ICR mice Inhibition of NF-κB activation. [230]
125 Tetrandrine Bisbenzylisoquinoline alkaloid Pachygone dasycarpa / DSS-induced acute colitis in mice Promoting occludin expression through the AhR-miR-429 pathway. [231]
40 mg DSS-induced acute colitis in C57BL/6 mice Inhibition of NF-κB activation. [232]
126 Norisoboldine Benzyl tetrahydroisoquinoline alkaloid Cassytha pubescens 40 mg TNBS-induced colitis in BALB/c mice Regulation of the AhR/Nrf2/ROS signaling pathway inhibits NLRP3 inflammasome activation. [233]
127 Dihydroberberine Isoquinoline alkaloid Thalictrum foliolosum 50 mg DSS-induced acute colitis in BALB/c mice Improved intestinal barrier function; reduced colonic pro-inflammatory cytokines and immunoglobulins by blocking TLR4/MyD88/NF-κB signaling pathway; improved colonic immune inflammation status. [234]
128 Palmatine Isoquinoline alkaloid Berberis poiretii 50 mg DSS-induced acute colitis in BALB/c mice Inhibition of tryptophan metabolism and regulation of intestinal flora. [235]
100 mg DSS-induced acute colitis in BALB/c mice Promoting PINK1/Parkin-driven mitochondrial autophagy and thereby inactivating NLRP3 inflammasome in macrophages. [236]
129 Coptisine Tetrahydroisoquinoline alkaloid Fumaria capreolata 100 mg DSS-induced acute colitis in BALB/c mice Improvement of intestinal barrier dysfunction and inhibition of inflammatory response. [237]
130 Sanguinarine Benzophenanthridine alkaloid Sanguinaria canadensis 10 mg Acetic acid-induced ulcerative colitis in Kunming mice Effective inhibition of p65 NF-κB protein expression and MPO activity accumulation. [238]
131 5-Hydroxy-4-methoxycanthin-6-one Indole alkaloid Picrasma quassioides 100 mg DSS-induced acute colitis in Sprague–Dawley rats Regulation of metabolic profile and inhibition of NF-κB/p65 signaling pathway. [239]`
132 Isatin Indole alkaloid Couroupita guianensis 25 mg TNBS-induced colitis in Wistar Hannover rats Protects the intestinal mucosa from TNBS-induced damage through a combination of antioxidant and anti-inflammatory properties. [240]
133 Caulerpin Indole alkaloid Caulerpa obscura 4 mg DSS-induced acute colitis in C57BL/6 mice Inhibition of NF-κB pathway activation. [241]
134 Indirubin Indole alkaloid Isatis tinctoria 10 mg DSS-induced acute colitis in BALB/c mice Inhibition of DSS-induced activation of NF-κB and MAPK pathways. [242]
10 mg DSS-induced acute colitis in BALB/c mice Inhibition of inflammation and induction of regulatory T cell expression foxp3. [243]
135 Rutaecarpine Indole alkaloid Tetradium ruticarpum 80 mg DSS-induced acute colitis in C57BL/6J mice Inhibition of KEAP1-NRF2 interaction and activation of NRF2. [244]
136 Daurisoline Isoquinoline alkaloid Menispermum dauricum 40 mg DSS-induced acute colitis in BALB/c mice Involved in NF-κB and Wnt/β-Catenin pathways. [245]
137 14-O-acetylneoline Diterpenoid alkaloid Aconitum laciniatum / TNBS-induced colitis in C57BL/6 mice Reduced IFN-γ mRNA levels in colonic tissues. [246]

“/” indicates that the reference is not mentioned or is unclear.